Factors influencing adjuvant treatment decision making among Chinese patients with hepatocellular carcinoma (HCC): Results of a patient survey.
Hui‐Chuan Sun(Fudan University), Jia Fan(Nanjing Tech University), Jian Zhou(Shenzhen University Health Science Center), Ying‐Hao Shen(Fudan University), Xiaodong Zhu(Guangxi Medical University), Li Xu(Fujian Medical University), Cheng Huang(Fudan University)
Cited by 3
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644